Sign up for the QMED & MD+DI Daily newsletter.
Sponsored By
The Worst-Performing Medtech IPOs Of 2014 (CareDx)The Worst-Performing Medtech IPOs Of 2014 (CareDx)
Location: Brisbane, CaliforniaProducts: Molecular diagnostics company focused on tests for heart transplant recipients
December 15, 2014
1 Min Read
.svg?width=850&auto=webp&quality=95&format=jpg&disable=upscale "The Worst-Performing Medtech IPOs Of 2014 (CareDx)")
Location: Brisbane, California
Products: Molecular diagnostics company focused on tests for heart transplant recipients
Date of IPO: July 16
IPO Offer Price: $10
Deal Size: $40 million
Returns: -30%
You May Also Like
.png?width=300&auto=webp&quality=80&disable=upscale)
.png?width=300&auto=webp&quality=80&disable=upscale)